tiprankstipranks
Trending News
More News >
Replimune Group Inc (REPL)
NASDAQ:REPL

Compare Replimune Group (REPL) vs. Competitors

Compare
476 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Replimune Group
$8.07
$581.31M
-3.16
-31.26%
1 Buy
2 Hold
0 Sell
Moderate Buy
Anavex Life Sciences
$4.65
$441.12M
-13.95
-45.87%
1 Buy
0 Hold
0 Sell
Moderate Buy
Arcus Biosciences
$22.11
$2.78B
-7.25
120.66%
7 Buy
3 Hold
0 Sell
Moderate Buy
Oric Pharmaceuticals
$13.71
$1.39B
-5.55
74.65%
11 Buy
0 Hold
0 Sell
Strong Buy
Nurix Therapeutics
$15.10
$1.57B
-5.54
7.47%
11 Buy
0 Hold
0 Sell
Strong Buy
Sana Biotechnology
$3.15
$910.02M
-4.22
23.53%
4 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
REPL
Replimune Group
8.07
-3.07
-27.56%
AVXL
Anavex Life Sciences
4.65
-4.34
-48.28%
RCUS
Arcus Biosciences
22.11
12.70
134.96%
ORIC
Oric Pharmaceuticals
13.71
6.08
79.69%
NRIX
Nurix Therapeutics
15.10
1.51
11.11%
SANA
Sana Biotechnology
3.15
0.63
25.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts